Hepatitis A, B and C viral co-infections among HIV-infected adults presenting for care and treatment at Muhimbili National Hospital in Dar es Salaam, Tanzania

BMC Public Health

Volumn 8, Issue , 2008, Pages

  Nagu, Tumaini J ^a   Bakari, Muhammad ^a   Matee, Mecky ^a  

^a MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HEPATITIS ANTIBODY; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ADOLESCENT; ADULT; AIDS RELATED COMPLEX; ARTICLE; BLOOD; CLASSIFICATION; COMORBIDITY; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGY; FEMALE; HEPATITIS A; HEPATITIS B; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; MALE; MIDDLE AGED; OUTPATIENT DEPARTMENT; RISK FACTOR; TANZANIA; UTILIZATION REVIEW;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOLOGICAL MARKERS; COMORBIDITY; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS A; HEPATITIS ANTIBODIES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; OUTPATIENT CLINICS, HOSPITAL; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; TANZANIA; YOUNG ADULT;

EID: 58249118844     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-8-416     Document Type: Article

References (28)

1. Report of the 3 by 5 Mission to Tanzania on Scaling up Antiretroviral Treatment as Part of the Global Emergency Response to HIV/AIDS. United Republic of Tanzania. Ministry of Health
2. National AIDS control program (NACP). United Republic of Tanzania. Ministry of Health, Annual report, Tanzania 2007
3. M Swash, Hutchison's clinical methods London Royal Hospital, Saunders Press 1995
4. Treat 3 million by 2005. Interim WHO clinical staging of HIV/AIDS and HIV/AIDS case definitions for surveillance. African region. WHO/HIV/2005.02. World Health Organization, http://www.who.int/hiv/pub/guidelines/ clinicalstaging.pdf
5. SPSS Inc version 10.0, The statistical Package for the Social Sciences Chicago, II: SPSS Inc 2004
6. Seroprevalence of hepatitis B and C viral co-infections among children infected with human immunodeficiency virus attending the paediatric HIV care and treatment center at Muhimbili National Hospital in Dar-es-Salaam, Tanzania. SP Telatela MI Mecky EK Munubhi, BMC Public Health 2007 7 338 18031586 10.1186/1471-2458-7-338
7. Seroprevalence of Human Immunodeficiency Virus, Hepatitis B and C Viruses and Syphilis Infections among Blood Donors at the Muhimbili National Hospital in Dar Es Salaam, Tanzania. MI Matee PM Magesa EF Lyamuya, BMC Public Health 2006 6 21 16445860 10.1186/1471-2458-6-21
8. Co-infection with HIV and HCV in Blood bank population in Dar es Salaam Tanzania. RD Waddell PM Magesa KJ Pallangyo MI Matee, J Clin Virol 2006 36 3 237 238 10.1016/j.jcv.2006.04.002 16723273
9. Prevalence of transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre in Dar es Salaam, Tanzania. MI Matee EF Lyamuya PM Magesa EC Mbena, East Afr Med J 1999 76 167 171 10442119
10. Hepatitis C serology and viremia in HIV-infected men. H Hollander T Wright M Held, Int Conf AIDS 9 358
11. Infection rate and spontaneous seroreversion of anti-hepatitis C virus infection in the general population. LA Kondili P Chione A Constantino, Gut 2002 50 693 696 11950818 10.1136/gut.50.5.693
12. Prevalence of hepatitis viruses in an anti-human immunodeficiency virus-positive population from Argentina - A multicentre study. H Fainboim J Gonzalez Fassio, J Viral Hepat 1999 6 1 53 57 10.1046/j.1365-2893.1999.t01-1- 6120135.x 10847130
13. Incidence of hepatitis B virus reactivation in HIV-1 infected patients. F Barin G Baty F Bastides F Dubois JM Besnier P Choutet A Goudeau, Antivir Ther 2003 8 1
14. Horizontal transmission of hepatitis B virus among children and adults in five rural villages in Zambia. E Tabor AC Bayley L Cairns RL Gerety, J Med Virol 1985 15 113 120 10.1002/jmv.1890150203 3973567
15. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa. MJ Mphahlele A Lukhwareni RJ Burnett LM Moropeng JM Ngobeni, J Clin Virol 2006 35 1 14 20 10.1016/j.jcv.2005.04.003 15916918
16. Prevalence of hepatitis A, B, C and human immunodeficiency virus seropositivity among patients with acute icteric hepatitis at the Kenyatta National Hospital, Nairobi. JO Atina O Ogutu Hardison, East Afr Med J 2004 81 4 183 187 15884283
17. Clinical aspects of the interactions between human immunodeficiency virus and the hepatotropic viruses. J Horvath SP Raffanti, Clin Infect Dis 1994 18 339 347 8011813
18. Analysis of causes for liver function deterioration in patients with HIV/HCV co-infection. YH Zhang XY Chen Y Jiang, Hepatobiliary Pancreat Dis Int 2004 3 4 538 542 15567741
19. The influence of HTLV-III infection on the natural history of hepatitis B virus infection in male homosexual HBsAg carriers. K Krogsgaard BO Lindhardt JO Nielson, Hepatol 1987 7 37 41 10.1002/hep.1840070109
20. Serological survey of Hepatitis B infection in Tanzania. G Plellzzer C Ble N Zamperetti, Public Health 1994 108 6 427 431 10.1016/S0033-3506(94)80100-2 7997492
21. Hepatitis C and Progression of HIV disease. MS Sulkowski RD Moore SH Mehta, JAMA 2002 288 2 241 243 10.1001/jama.288.2.199 12095390
22. HBV, HIV co-infection at Kisumu District Hospital, Kenya. AE Otedo, East Afr Med J 2004 81 12 626 630 15868977
23. Diminished frequency of Hepatitis C virus specific interferon γ secreting CD4+ T cells in Human immunodeficiency virus co-infected patients. G Harcourt E Gomperts S Donfield P Klenerman, Gut 2006 55 1484 1487 16543291 10.1136/gut.2005.083758
24. National Guidelines for the Clinical Management of HIV and AIDS. The United Republic of Tanzania. Ministry of Health. National AIDS Control Program, 2 2005
25. Tenofovir Disoproxil Fumarate and Lamivudine Combination Therapy Compared to Lamivudine Alone for HBV in Therapy-naive HIV/HBV Co-infected Patients: 48-week Interim Results. D Cooper G Dore AL Pozniak, 10th Conf Retrovir Oppor Infect 2003 10 10 14
26. Short statement of the first european consensus Conference on the treatment of chronic Hepatitis B and C in HIV co-infected patients. A Alberti N Clumeck S Collins W Gerlich J Lundgren G Palu' P Reiss R Thiebaut O Weiland Y Yazdanpanah S Zeuzem, Hepatol 2005 42 615 624 10.1016/j.jhep.2005.03.003
27. Hepatitis B Virus and HIV Co-Infection: Development of Lamivudine Resistance. L Cooley A Bartholomeusz A Ayres, 9th Conf Retrovir Oppor Infect 2002 24 28
28. Nevirapine toxicity in a cohort of HIV-1 infected pregnant women. E João G Calvet J Menezes, Am J Obstet Gynecol 2006 194 199 202 10.1016/j.ajog.2005.05.015 16389032